<DOC>
	<DOCNO>NCT00875641</DOCNO>
	<brief_summary>This observational cohort study , conduct two exist large administrative health database US ( outside Vaccine Safety Datalink ) plan confirm safety profile regard lack association intussusception Rotarix within 60 day vaccination real life setting ( routine use ) US . This study also include monitor Kawasaki disease , convulsion , hospitalization due acute low respiratory tract infection all-cause death within 60-days vaccination . This study involve three cohort , one expose two control cohort : infant receive Rotarix ( Exposed cohort ) infant receive IPV vaccination ( Unexposed cohort A B ) . This combined prospective retrospective cohort study . Prospective component study identifies compare study outcome follow Rotarix IPV vaccination Exposed cohort Unexposed cohort A , respectively . Retrospective component study identifies compare study outcome follow IPV vaccination Unexposed cohort B .</brief_summary>
	<brief_title>Safety Study GSK Biologicals ' Rotavirus Vaccine ( Rotarix® ) Administered Children Aged &lt; 1 Year United States</brief_title>
	<detailed_description />
	<mesh_term>Rotavirus Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>For Exposed cohort : Infants age less 1 year study entry . Infants enrol one two participate health insurance plan databases within 30 day birth . Have complete medical coverage pharmacy benefit . Received least one dose Rotarix 1 August 2008 . Infants receive Rotarix liquid formulation also eligible . For Unexposed cohort A : Infants age less 1 year study entry . Infants enrol one two participate health insurance plan databases within 30 day birth . Have complete medical coverage pharmacy benefit . Received least one dose IPV vaccine 1 August 2008 , without RotaTeq vaccination . Frequencymatched Rotarix cohort gender , age first vaccination ( ±1 week ) calendar quarter vaccination within year . For Unexposed cohort B : Infants enrol one two participate health insurance plan databases within 30 day birth . Had complete medical coverage pharmacy benefit . Received least one dose IPV vaccine . Vaccinated 1 January 2006 ( inclusive ) 31 July 2008 ( inclusive ) . Not receive dose rotavirus vaccination . Frequencymatched Rotarix cohort gender , age first vaccination ( ±1 week ) calendar quarter vaccination . For Exposed cohort : • Subject receive dose RotaTeq prior first Rotarix vaccine study period . For Unexposed cohort A : • Subject receive dose Rotarix prior first IPV vaccine study period . For Unexposed cohort B : • Subject receive dose rotavirus vaccine prior first IPV vaccine .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>1 Year</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>